Medication info
Esoprazole 40 mg (Esomeprazole Magnesium Trihydrate)

Esoprazole 40 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
IQURE Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
28 tablets/box [(7 tablets/Alu-Alu x 4)]
Approval status
Active

MFDS item code 201602287 · Approved 2016.04.25 · Insurance code 674400830

Summary

Main use
Treatment of acid-related disorders (reflux, ulcers, etc.), Helicobacter pylori eradication, and gastrointestinal disorders caused by anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. Administer 40 mg once daily. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of developing gastric and duodenal ulcers due to NSAID use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue for as long as clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because experience administering this medicine to patients with severe renal impairment is limited. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older: Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Adolescents aged 12 years and older: In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of developing gastric and duodenal ulcers due to NSAID use. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
IQURE Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (reflux, ulcers, etc.), Helicobacter pylori eradication, and gastrointestinal disorders caused by anti-inflammatory analgesics

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcer with Helicobacter pylori positive
  • peptic ulcer
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers related to the administration of non-steroidal anti-inflammatory drugs
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This drug is used for the treatment and prevention of gastroesophageal reflux disease and erosive reflux esophagitis. It is also effective in treating and preventing relapse in patients with duodenal ulcers and gastric ulcers caused by Helicobacter pylori infection. It is used to treat pain and discomfort in the upper gastrointestinal tract caused by the intake of non-steroidal anti-inflammatory drugs and is also helpful in treating gastric ulcers and preventing ulcers. It is used for the treatment of Zollinger-Ellison syndrome and maintenance therapy to prevent rebleeding from gastric and duodenal ulcers after intravenous administration. Overall, it is used for the treatment and prevention of various gastrointestinal-related diseases.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. Administer 40 mg once daily. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of developing gastric and duodenal ulcers due to NSAID use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials extending beyond 4 weeks have not been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue for as long as clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Use with caution because experience administering this medicine to patients with severe renal impairment is limited. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older: Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Adolescents aged 12 years and older: In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of developing gastric and duodenal ulcers due to NSAID use. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This drug should not be administered to certain patients. For example, those with allergies or hypersensitivity reactions to this drug or its ingredients, or benzimidazole derivatives should avoid taking it. Patients allergic to certain antibiotics (penicillins, macrolides) used in conjunction with this drug for the eradication of Helicobacter pylori should also not be given this medication. Patients taking certain heart-related medications or antiviral drugs, and breastfeeding women should not use this drug. Caution is needed in patients with a history of myocardial infarction. Various adverse reactions may occur when taking this drug. Commonly reported effects include headache, abdominal pain, diarrhea, constipation, and nausea, while rare adverse effects include blood disorders, neurological disorders, liver function abnormalities, skin rashes, and severe allergic reactions. Long-term use may cause electrolyte imbalances, such as hypomagnesemia, requiring regular monitoring. Additionally, since this drug suppresses stomach acid, there may be a slightly increased risk of bacterial infections in the gastrointestinal tract. Long-term or high-dose use may increase the risk of fracture, so caution is warranted in patients at risk for osteoporosis. It is important to take this medication at the minimum dose and duration under the guidance of a physician. This drug may interact with other medications; therefore, particularly when taken with anticoagulants, antibiotics, antivirals, antiepileptics, etc., it is essential to consult a doctor or pharmacist. Data on the safety of this drug during pregnancy is limited, so it should be used cautiously under a doctor's judgment during pregnancy, and it should be avoided while breastfeeding. In case of overdose, since there is no specific antidote, treatment should be supportive according to symptoms, and this drug is not removed by dialysis. This drug should be stored out of reach of children and should not be transferred to other containers.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorders, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, liver enzyme elevation, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane pemphigoid, Stevens-Johnson syndrome, toxic epidermal necrolysis, Liell syndrome, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, hyperhidrosis, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, flushing, hypertension, tachycardia, thyroid tumor, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, worsening of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to protect it from air and moisture. It is best to keep it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

28 tablets/box [(7 tablets/Alu-Alu x 4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.